๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Comparative pharmacokinetics of midazolam and loprazolam in healthy subjects after oral administration

โœ Scribed by R. Jochemsen; P. A. Van Rijn; T. G. M. Hazelzet; C. J. Van Boxtel; D. D. Breimer


Publisher
John Wiley and Sons
Year
1986
Tongue
English
Weight
397 KB
Volume
7
Category
Article
ISSN
0142-2782

No coin nor oath required. For personal study only.

โœฆ Synopsis


The pharmacokinetics of oral midazolam (Dormicum@, 15 mg) and loprazolam (Dormonoct@, 1 mg) were studied in eight healthy young volunteers in a cross-over design. Plasma concentrations of midazolam were measured with a gas chromatographic method and loprazolam concentrations were determined by a radio-receptor technique. Absorption of midazolam proceeded very rapidly (median t,,, = 0.4 h) and a rapid onset of sedative action was observed. Loprazolam absorption was relatively slow (median tmax = 3 h) and its absorption profile was often irregular. Most subjects fell asleep before peak concentrations were reached. Median peak concentrations were 94 ng ml-' and 3.1 ng ml-' for midazolam and Ioprozolam, respectively. The median elimination half-life of midazolam was 1.8 h and that of loprazolam 15 h. It is possible that the elimination half-life of loprazolam as determined by radioreceptor assay is determined by active metabolites rather than by loprazolam itself. Midazolam elimination half-life was the same when determined by radioreceptor assay or by GLC. There was no significant correlation between the half-lives of the two drugs.


๐Ÿ“œ SIMILAR VOLUMES


Pharmacokinetics of ketotiffn after oral
โœ Dr A. Grahnรฉn; A. Lรถnnebo; O. Beck; S-ร… Eckernรคs; B. Dahlstrรถm; B. Lindstrรถm ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 406 KB ๐Ÿ‘ 2 views

## Abstract The pharmacokinetics of 2 mg ketotifen from four different oral dosage forms were examined in two randomized, balanced crossโ€over studies. Forty healthy male subjects participated. Each of 20 subjects received two capsule formulations and each of the other 20 subjects received two syrup

Pharmacokinetics of fluvoxamine maleate
โœ M. H. De Vries; J. Van Harten; P. Van Bemmel; M. Raghoebar ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 286 KB ๐Ÿ‘ 2 views

The pharmacokinetics of fluvoxamine after single oral administration of 25, 50, and 100mg fluvoxamine maleate was studied in a three-way cross-over study in 12 healthy male subjects. Fluvoxamine was administered orally in a solution. For doseproportionality, AUC, and C,-dose relationships were evalu

Nefopam enantiomers: Preclinical pharmac
โœ Gary G. Mather; Rita Labroo; Marie-Emmanuelle Le Guern; Francis Lepage; Jean-Mar ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 133 KB

Nefopam (NEF) is a potent analgesic compound administered as a racemic mixture. Previous in vitro and in vivo studies with nefopam enantiomers have shown that (+)nefopam [(+)NEF] is substantially more potent than (-)nefopam [(-)NEF]. Differences between enantiomers have also been suggested in metabo

Pharmacokinetics of orally administered
โœ M. Van Der Graaff; N. P. E. Vermeulen; P. Heij; J. K. Boeijinga; D. D. Breimer ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 375 KB ๐Ÿ‘ 1 views

Hexobarbital (HB) concentrations were determined in plasma and saliva of 8 healthy subjects, following oral administration of 500 mg HB-Na. Mean plasma half-lives were 3.2 k 0.1 h, and salivary half-lives 3.3 k 0.2 h. Mean plasma clearance was 22.9 k 2.3 1 h-'. There was a linear relationship betwee

PHARMACOKINETICS OF SUPEROXIDE DISMUTASE
โœ C. Regnault; M. Soursac; M. Roch-Arveiller; E. Postaire; G. Hazebroucq ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 479 KB ๐Ÿ‘ 2 views

The kinetic behaviour of bovine erythrocyte Cu-Zn SOD was investigated in Sprague Dawley male rats after subcutaneous and oral administrations of doses ranging from 0.5 to 20mgkg-I. Studies have been carried out with SOD and SOD encapsulated into liposomes containing or not containing ceramides. The